2篇
您的检索式：作者名="Luoyang Tu"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | INVESTIGATION OF PHYSICO METALLURGICAL PHENOMENA FOR THE CC FORMING OF WCP/Fe C COMPOSITES显示文摘Theinvestigation of physicometallurgicalphenomena forthe CC formingof WCP/ Fe Ccom posites wasperformed. Resultsshow that underthe patentcondition, WCP/ Fe Ccomposite surfacelayerof16 20 m m heavycross sectioncan beacquiredintheoutsideofa hollow cylin der. The surface of CTC particlescould be partially dissolved by Fe containing melt. Thefineshortstick like WCcrystallitesarein situseparated neartothesurfaceof CTC particles.Far from the CTC particles,someseparated, finetungsten carbidecrystallitesand Fe, W,Mo and Cretc. containing web composite carbides, are distributed on the matrix of WCP/ Fe Ccomposite. Fe Calloy matrix of the hollow composite cylinder is alloyed in differenthigh levels. | B.Z. Li1) ,Y.P. Song1) ,K.U. Kainer2) , H. Zhang3) , J.P.Xie1) and R.Xiang4) 1) Department of Materials Engineering ,Luoyang Institute of Technology ,Luoyang 471039 ,China2) Institute of Material Science and Technology ,TU Clausthal,D 38678 Clausthal | 1999 | Acta Metallurgica Sinica(English Letters)1999，12，4： | 1 |
| 2 | A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD显示文摘The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has caused a global pandemic of novel coronavirus disease(COVID-19).The neutralizing monoclonal antibodies(mAbs)targeting the receptor-binding domain(RBD)of SARS-CoV-2 are among the most promising strategies to prevent and treat COVID-19.However,SARS-CoV-2 variants of concern(VOCs)profoundly reduced the efficacies of most of mAbs and vaccines approved for clinical use.Herein,we demonstrated mAb 35B5 efficiently neutralizes both wild-type(WT)SARS-CoV-2 and VOCs. | Xiaofei Wang Ao Hu Xiangyu Chen Yixin Zhang Fei Yu Shuai Yue Arong Li Junsong Zhang Zhiwei Pan Yang Yang Yao Lin Leiqiong Gao Jing Zhou Jing Zhao Fang Li Yaling Shi Feng Huang Xiaofan Yang Yi Peng Luoyang Tu Huan Zhang Huanying Zheng Jun He Hui Zhang Lifan Xu Qizhao Huang Yongqun Zhu Kai Deng Lilin Ye | 2022 | Signal Transduction and Targeted Therapy2022，7，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员